CUSIP: 72940R102
Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,724,987
-
Share change
-
+2,428,957
-
Total reported value
-
$8,456,000
-
Put/Call ratio
-
105%
-
Price per share
-
$0.97
-
Number of holders
-
30
-
Value change
-
+$2,356,072
-
Number of buys
-
15
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP 72940R102?
CUSIP 72940R102 identifies PSTI - PLURISTEM THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2019
-
Previous quarter:
Q4 2018
Recent filing periods for CUSIP 72940R102:
Institutional Holders of PLURISTEM THERAPEUTICS INC - COM (PSTI) as of Q1 2019
As of 31 Mar 2019,
PLURISTEM THERAPEUTICS INC - COM (PSTI) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,724,987 shares.
The largest 10 holders included
ARK Investment Management LLC, RENAISSANCE TECHNOLOGIES LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., ETF MANAGERS GROUP, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Psagot Investment House Ltd., JANE STREET GROUP, LLC, RAYMOND JAMES & ASSOCIATES, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.